Search
for
Sort by
Research 301–330 of 1000+
- Gut microbiome, metabolome and alopecia areata
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Unmasking pseudopelade of Brocq in male adult: a rare case report
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Application of microneedle patches for drug delivery; doorstep to novel therapies
- Dermatologic manifestations of thyroid disease: a literature review
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Prostaglandins: Key players in immunomodulation of the nervous system
- Comorbidities of Primary Scarring Alopecias: A Retrospective Multi‐Site Cross‐Sectional Study
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Skin manifestations associated with systemic diseases – Part I
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Pharmacological Activity of Cepharanthine
- Skin Sceneries of Thyroid Disorders and Impact of Thyroid on Different Skin Diseases: A Scoping Review Focused on Pediatric Patients
- Segmental Vitiligo
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Recalcitrant widespread alopecia areata in a child treated successfully with oral methylprednisolone pulse therapy